1 | protocol | 13,514 |
2 | setup | 354 |
3 | set-up | 116 |
4 | 0003 | 10 |
5 | mgpa | 10 |
6 | drvh | 8 |
7 | phototesting | 3 |
8 | plaquette | 3 |
9 | procotol | 3 |
10 | snc80 | 3 |
11 | 58951 | 2 |
12 | gillnet | 2 |
13 | ici-182,780 | 2 |
14 | k41498 | 2 |
15 | low-sar | 2 |
16 | ly367385 | 2 |
17 | mono-intoxication | 2 |
18 | ro25-6981 | 2 |
19 | treatment.this | 2 |
20 | 2-chloro-n6-cyclopentanyladenosine | 1 |
21 | 2-methylthio-adp | 1 |
22 | 4-phenyl-2-propionamidotetraline | 1 |
23 | 7-hydroxy-n | 1 |
24 | 8-hydroxy-n | 1 |
25 | a-425619 | 1 |
26 | atap-2 | 1 |
27 | atpo | 1 |
28 | borrill | 1 |
29 | bq788 | 1 |
30 | brl-44408 | 1 |
31 | c12-iedap | 1 |
32 | cgp55845 | 1 |
33 | cgrp8-37 | 1 |
34 | cgs19755 | 1 |
35 | clocinnamox | 1 |
36 | counciltrial | 1 |
37 | d-pro4 | 1 |
38 | day.well | 1 |
39 | diprenorphine | 1 |
40 | e-5564 | 1 |
41 | f17141 | 1 |
42 | gaba-release | 1 |
43 | genotype-uncorrected | 1 |
44 | groups.trial | 1 |
45 | gw1929 | 1 |
46 | hc-03001 | 1 |
47 | induced-cancer | 1 |
48 | ly278584 | 1 |
49 | mastoparan-7 | 1 |
50 | mixed-initiative | 1 |
51 | mrs5698 | 1 |
52 | n-n-butyl-3-methoxy | 1 |
53 | pnda-3 | 1 |
54 | protocol/itt | 1 |
55 | protokol | 1 |
56 | questionnaire-interviews | 1 |
57 | sb204741 | 1 |
58 | sb225002 | 1 |
59 | sp-8-br-pet-cgmp | 1 |
60 | t0070907 | 1 |
61 | thiphenamil | 1 |
62 | trihydroxide | 1 |
63 | vericiguat | 1 |
64 | year-woman | 1 |
65 | zonampanel | 1 |
1 | 0003 | 10 |
2 | 2-chloro-n6-cyclopentanyladenosine | 1 |
3 | 2-methylthio-adp | 1 |
4 | 4-phenyl-2-propionamidotetraline | 1 |
5 | 58951 | 2 |
6 | 7-hydroxy-n | 1 |
7 | 8-hydroxy-n | 1 |
8 | a-425619 | 1 |
9 | atap-2 | 1 |
10 | atpo | 1 |
11 | borrill | 1 |
12 | bq788 | 1 |
13 | brl-44408 | 1 |
14 | c12-iedap | 1 |
15 | cgp55845 | 1 |
16 | cgrp8-37 | 1 |
17 | cgs19755 | 1 |
18 | clocinnamox | 1 |
19 | counciltrial | 1 |
20 | d-pro4 | 1 |
21 | day.well | 1 |
22 | diprenorphine | 1 |
23 | drvh | 8 |
24 | e-5564 | 1 |
25 | f17141 | 1 |
26 | gaba-release | 1 |
27 | genotype-uncorrected | 1 |
28 | gillnet | 2 |
29 | groups.trial | 1 |
30 | gw1929 | 1 |
31 | hc-03001 | 1 |
32 | ici-182,780 | 2 |
33 | induced-cancer | 1 |
34 | k41498 | 2 |
35 | low-sar | 2 |
36 | ly278584 | 1 |
37 | ly367385 | 2 |
38 | mastoparan-7 | 1 |
39 | mgpa | 10 |
40 | mixed-initiative | 1 |
41 | mono-intoxication | 2 |
42 | mrs5698 | 1 |
43 | n-n-butyl-3-methoxy | 1 |
44 | phototesting | 3 |
45 | plaquette | 3 |
46 | pnda-3 | 1 |
47 | procotol | 3 |
48 | protocol | 13,514 |
49 | protocol/itt | 1 |
50 | protokol | 1 |
51 | questionnaire-interviews | 1 |
52 | ro25-6981 | 2 |
53 | sb204741 | 1 |
54 | sb225002 | 1 |
55 | set-up | 116 |
56 | setup | 354 |
57 | snc80 | 3 |
58 | sp-8-br-pet-cgmp | 1 |
59 | t0070907 | 1 |
60 | thiphenamil | 1 |
61 | treatment.this | 2 |
62 | trihydroxide | 1 |
63 | vericiguat | 1 |
64 | year-woman | 1 |
65 | zonampanel | 1 |
1 | ici-182,780 | 2 |
2 | snc80 | 3 |
3 | hc-03001 | 1 |
4 | f17141 | 1 |
5 | sb204741 | 1 |
6 | 58951 | 2 |
7 | ro25-6981 | 2 |
8 | atap-2 | 1 |
9 | sb225002 | 1 |
10 | pnda-3 | 1 |
11 | 0003 | 10 |
12 | e-5564 | 1 |
13 | ly278584 | 1 |
14 | d-pro4 | 1 |
15 | cgp55845 | 1 |
16 | cgs19755 | 1 |
17 | ly367385 | 2 |
18 | mastoparan-7 | 1 |
19 | t0070907 | 1 |
20 | cgrp8-37 | 1 |
21 | brl-44408 | 1 |
22 | bq788 | 1 |
23 | k41498 | 2 |
24 | mrs5698 | 1 |
25 | a-425619 | 1 |
26 | gw1929 | 1 |
27 | mgpa | 10 |
28 | genotype-uncorrected | 1 |
29 | trihydroxide | 1 |
30 | diprenorphine | 1 |
31 | 4-phenyl-2-propionamidotetraline | 1 |
32 | 2-chloro-n6-cyclopentanyladenosine | 1 |
33 | gaba-release | 1 |
34 | plaquette | 3 |
35 | mixed-initiative | 1 |
36 | phototesting | 3 |
37 | drvh | 8 |
38 | groups.trial | 1 |
39 | counciltrial | 1 |
40 | zonampanel | 1 |
41 | thiphenamil | 1 |
42 | day.well | 1 |
43 | borrill | 1 |
44 | protocol | 13,514 |
45 | protokol | 1 |
46 | procotol | 3 |
47 | 7-hydroxy-n | 1 |
48 | 8-hydroxy-n | 1 |
49 | year-woman | 1 |
50 | mono-intoxication | 2 |
51 | atpo | 1 |
52 | c12-iedap | 1 |
53 | 2-methylthio-adp | 1 |
54 | sp-8-br-pet-cgmp | 1 |
55 | set-up | 116 |
56 | setup | 354 |
57 | low-sar | 2 |
58 | induced-cancer | 1 |
59 | treatment.this | 2 |
60 | questionnaire-interviews | 1 |
61 | vericiguat | 1 |
62 | gillnet | 2 |
63 | protocol/itt | 1 |
64 | clocinnamox | 1 |
65 | n-n-butyl-3-methoxy | 1 |